Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evidence-based evaluation and mechanism of Xuebijing Injection in the prevention and treatment of sepsis
ChiCTR2100045089Phase 4Recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Nov 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of xuebijing in sepsis (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoint: SOFA score improvement. Started Nov 2020; status: recruiting.
02
Drugs
xuebijing
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2100045089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045089.